Pfizer (NYSE: PFE), multinational pharmaceutical company, acquired Array BioPharma Inc. (Nasdaq: ARRY), a biopharmaceutical company focused on small molecule medicines, for $11.4 billion.
Morrow Sodali acted as the proxy solicitor for the bidder in this transaction.